SILVER SPRING, Md. — The public is getting a second chance to have their say on Swedish Match's bid to have its General snus labeled as a modified risk tobacco product (MRTP).
The Food and Drug Administration (FDA) has reopened the public comment period for the MRTP applications submitted last year by Swedish Match North America Inc. for 10 snus smokeless tobacco products.
The second round of comments specifically applies to amendments to the originally filed applications, according to the agency. After filing the applications for scientific review — the first MRTP applications to reach this milestone — the FDA requested clarifying and other information from the company and received several amendments in response.
Comments on the amendments should be submitted to the docket by Aug. 31.